A new review of data for Roche's flu drug Tamiflu has concluded the drug does not reduce hospitalisations and serious complications of the virus – and that it leads to harmful effects in ...

The MH recommends that pregnant and puerperal women with influenza-like syndrome and at risk for COVID-19, even if immunized, be treated with Oseltamivir in the usual dose in order to reduce maternal ...